Nosocomial infections caused by Elizabethkingia meningoseptica: An emergent pathogen

Brazilian Journal of Infectious Diseases

Volumn 17, Issue 5, 2013, Pages 606-609

  Pereira, Graziella H ^a   Garcia, Doroti de Oliveira ^b   Abboud, Cely Saad ^a   Barbosa, Vera Lucia de Barros ^a   da Silva, Paulo Sérgio Lucas ^c  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c HOSPITAL BRIGADEIRO   (Brazil)

Author keywords

Bloodstream infections; Elizabethkingia meningoseptica; Nosocomial infections

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; MINOCYCLINE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CATHETER INFECTION; CHILD; CLINICAL ARTICLE; ELIZABETHKINGIA MENINGOSEPTICA; ELIZABETHKINGIA MENINGOSEPTICA INFECTION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; HYPOALBUMINEMIA; INCIDENCE; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MEDICAL RECORD; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRESCHOOL CHILD; PREVALENCE; SHOCK; TACHYCARDIA; URINARY CATHETER;

BLOODSTREAM INFECTIONS; ELIZABETHKINGIA MENINGOSEPTICA; NOSOCOMIAL INFECTIONS;

AGED; AGED, 80 AND OVER; BRAZIL; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; CROSS INFECTION; FEMALE; FLAVOBACTERIACEAE INFECTIONS; HUMANS; INFANT; MALE; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84884722414     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2013.02.011     Document Type: Article

References (16)

1. Hsu M.S., Liao C.H., Huang Y.T., et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. Eur J Clin Microbiol Infect Dis 2011, 30:1271-1278.
2. Dipentima M.C., Mason E.O., Kaplan S.L. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options. Clin Infect Dis 1998, 26:1169-1176.
3. Bloch K.C., Nadarajah R., Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 1997, 76:30-41.
4. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
5. Performance standards for antimicrobial susceptibility testing, 21th informational supplement CLSI document M100-S21 2011, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA, USA.
6. Maraki S., Scoulica E., Manoura A., Papageorgiou N., Giannakopoulou C., Galanakis E. A Chryseobacterium meningosepticum colonization outbreak in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 2009, 28:1415-1419.
7. Ceyhan M., Yildirim I., Tekeli A., et al. A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients. Am J Infect Control 2008, 36:453-457.
8. Lin Y.T., Chiu C.H., Chan Y.J., et al. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan. Scand J Infect Dis 2009, 41:628-634.
9. Weaver K.N., Jones R.C., Albright R., et al. Acute emergence of Elizabethkingia meningoseptica infection among mechanically ventilated patients in a long-term acute care facility. Infect Control Hosp Epidemiol 2010, 31:54-58.
10. Wang J.L., Chen M.L., Lin Y.E., Chang S.C., Chen Y.C. Association between contaminated faucets and colonization or infection by nonfermenting gram-negative bacteria in intensive care units in Taiwan. J Clin Microbiol 2009, 47:3226-3230.
11. Güngör S., Özen M., Akinci A., Durmaz R.A. Chryseobacterium miningosepticum outbreak in a neonatal ward. Infect Control Hosp Epidemiol 2003, 8:613-617.
12. Lin P.Y., Chen H.L., Huang C.T., Su L.H., Chiu C.H. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia. Int J Antimicrob Agents 2010, 36:436-440.
13. Raad I., Hanna H., Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007, 7:645-657.
14. Bellais S., Aubert D., Naas T., Nordmann P. Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing β-lactamases in Chryseobacterium meningosepticum. Antimicrob Agents Chemother 2000, 44:1878-1886.
15. Lin Y.T., Chan Y.J., Chiu C.H., et al. Tigecycline and colistin susceptibility of Chryseobacterium meningosepticum isolated from blood in Taiwan. Int J Antimicrob Agents 2009, 34:100-101.
16. Hung P.P., Lin Y.H., Lin C.F., Liu M.F., Shi Z.Y. Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality. J Microbiol Immunol Infect 2008, 41:137-144.